Stephen G. Gaffney
Stephen G. Gaffney
Associate Research Scientist, Yale University
Verified email at yale.edu
Title
Cited by
Cited by
Year
Early and multiple origins of metastatic lineages within primary tumors
ZM Zhao, B Zhao, Y Bai, A Iamarino, SG Gaffney, J Schlessinger, ...
Proceedings of the National Academy of Sciences 113 (8), 2140-2145, 2016
882016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
H Kadara, M Choi, J Zhang, ER Parra, J Rodriguez-Canales, SG Gaffney, ...
Annals of Oncology 28 (1), 75-82, 2017
672017
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function
M Choi, H Kadara, J Zhang, ER Parra, J Rodriguez-Canales, SG Gaffney, ...
Annals of Oncology 28 (1), 83-89, 2017
412017
Harnessing case isolation and ring vaccination to control Ebola
C Wells, D Yamin, ML Ndeffo-Mbah, N Wenzel, SG Gaffney, JP Townsend, ...
PLoS Negl Trop Dis 9 (5), e0003794, 2015
292015
Effect sizes of somatic mutations in cancer
VL Cannataro, SG Gaffney, JP Townsend
JNCI: Journal of the National Cancer Institute 110 (11), 1171-1177, 2018
212018
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
VL Cannataro, SG Gaffney, T Sasaki, N Issaeva, NKS Grewal, JR Grandis, ...
Oncogene 38 (18), 3475-3487, 2019
122019
CDKN2A copy number loss is an independent prognostic factor in HPV-negative head and neck squamous cell carcinoma
WS Chen, RS Bindra, A Mo, T Hayman, Z Husain, JN Contessa, ...
Frontiers in oncology 8, 95, 2018
102018
Combined Aurora kinase A (AURKA) and WEE1 inhibition demonstrates synergistic antitumor effect in squamous cell carcinoma of the head and neck
JW Lee, J Parameswaran, T Sandoval-Schaefer, KJ Eoh, D Yang, F Zhu, ...
Clinical Cancer Research 25 (11), 3430-3442, 2019
92019
Heterogeneity and mutation in KRAS and associated oncogenes: evaluating the potential for the evolution of resistance to targeting of KRAS G12C
VL Cannataro, SG Gaffney, C Stender, ZM Zhao, M Philips, AE Greenstein, ...
Oncogene 37 (18), 2444-2455, 2018
92018
Characterizing risk of Ebola transmission based on frequency and type of case–contact exposures
LA Skrip, MP Fallah, SG Gaffney, R Yaari, D Yamin, A Huppert, L Bawo, ...
Philosophical Transactions of the Royal Society B: Biological Sciences 372 …, 2017
62017
Molecular biology and evolution of cancer: from discovery to action
JA Somarelli, H Gardner, VL Cannataro, EF Gunady, AM Boddy, ...
Molecular Biology and Evolution 37 (2), 320-326, 2020
32020
CDKN2A copy number loss in HPV-and HPV+ head and neck cancer to indicate poor prognosis: An integrated genomic and clinical TCGA analysis.
WS Chen, R Bindra, A Mo, T Hayman, Z Husain, JN Contessa, ...
Journal of Clinical Oncology 35 (15_suppl), 6060-6060, 2017
32017
PathScore: a web tool for identifying altered pathways in cancer data
SG Gaffney, JP Townsend
Bioinformatics 32 (23), 3688-3690, 2016
22016
Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma
L Lu, SG Gaffney, VL Cannataro, J Townsend
Oral Oncology 101, 104554, 2020
12020
Mutation and immune profiles in early-stage lung squamous cell carcinoma
M Choi, H Kadara, J Zhang, EP Cuentas, JR Canales, SG Gaffney, ...
Cancer Research 76 (14 Supplement), 142-142, 2016
12016
Number of HIV-1 founder variants is determined by the recency of the source partner infection
CJ Villabona-Arenas, M Hall, KA Lythgoe, SG Gaffney, RR Regoes, ...
Science 369 (6499), 103-108, 2020
2020
SEX-SPECIFIC GLIOMA MOLECULAR SIGNATURES
E Claus, V Cannataro, S Gaffney, J Townsend
NEURO-ONCOLOGY 21, 80-80, 2019
2019
The landscape of novel and complementary targets for immunotherapy: an analysis of gene expression in the tumor microenvironment
SG Gaffney, EB Perry, PM Chen, A Greenstein, SM Kaech, JP Townsend
Oncotarget 10 (44), 4532, 2019
2019
GEM-NET: Lessons in Multi-Institution Teamwork Using Collaboration Software
SG Gaffney, O Ad, S Smaga, A Schepartz, JP Townsend
ACS central science 5 (7), 1159-1169, 2019
2019
HIV-1 founder variant multiplicity is determined by the infection stage of the source partner
CJ Villabona-Arenas, M Hall, KA Lythgoe, SG Gaffney, RR Regoes, ...
medRxiv, 19013524, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20